APA (7th ed.) Citation

Reck, M., Mileham, K., Clump, D., Decoster, L., Estival, A., Felip, E., . . . Smit, E. (2020). 1420TiP A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC). Annals of Oncology, 31, S897. https://doi.org/10.1016/j.annonc.2020.08.1734

Chicago Style (17th ed.) Citation

Reck, M., et al. "1420TiP A Phase I/II Trial of Radium-223 (Ra-223) in Combination with Pembrolizumab in Patients (pts) with Stage IV Non-small Cell Lung Cancer (NSCLC)." Annals of Oncology 31 (2020): S897. https://doi.org/10.1016/j.annonc.2020.08.1734.

MLA (9th ed.) Citation

Reck, M., et al. "1420TiP A Phase I/II Trial of Radium-223 (Ra-223) in Combination with Pembrolizumab in Patients (pts) with Stage IV Non-small Cell Lung Cancer (NSCLC)." Annals of Oncology, vol. 31, 2020, p. S897, https://doi.org/10.1016/j.annonc.2020.08.1734.